Thymosin alpha-1 5mg

2025-10-02T15:02:33+03:00

Price: 59.00

What is Thymosin Alpha-1?

Thymosin Alpha-1 (Tα1) is a natural peptide, originally isolated from the thymus gland, consisting of 28 amino acids. In scientific literature, Tα1 has been studied as an immunomodulatory agent involved in the regulation of innate and adaptive immune responses. The synthetic analog of the peptide is used in laboratory settings to study mechanisms related to T-cell activation, inflammatory control, and cellular defense.

Thymosin Alpha-1 is a subject of scientific interest due to its ability to activate T-lymphocytes, enhance the expression of HLA class I antigens, and modulate the production of cytokines such as IL-2 and IFN-γ. In research settings, it has been used as a tool to study cellular immune regulation, antiviral defense, and immune balance in chronic inflammation.

Observations on Thymosin Alpha-1

In scientific literature, Thymosin Alpha-1 has been studied in connection with:

Regulation of immune response – activation of T-cells and NK-cells

Enhancement of cellular immunity – stimulation of cytokine secretion (IL-2, IFN-γ)

Antiviral activity – studies on the modulation of antiviral mechanisms

Immune homeostasis – restoration of balance between Th1 and Th2 responses

Improvement of response to vaccines and immune stimulants

Investigation of its role in autoimmune and inflammatory models

Administration and Dosage

In scientific literature, Thymosin Alpha-1 dosages typically range between 0.8 – 1.6 mg, administered subcutaneously, 2–3 times a week, depending on the scientific study. In preclinical studies, doses are often adjusted to the target immune activation.

With 5 mg + 3 ml bacteriostatic water:

Concentration = 1.67 mg/ml → 0.6 ml = 1 mg

Example values:

0.6 ml = 1 mg

1.2 ml = 2 mg

Scientific Data

Thymosin Alpha-1 has been the subject of numerous studies in the fields of immunology and cell biology.

In cell models, it activates T-lymphocytes and increases the expression of CD3 and CD8 markers

Enhances the secretion of interferon-γ and interleukin-2, key mediators of cellular immunity

In vivo models have shown protection against viral and bacterial agents

Improves antioxidant defense and cell resistance to oxidative stress

Regulates apoptotic processes and cellular recovery

Application in Research Settings

In laboratory research, the peptide is used to study:

Cellular mechanisms of immune activation

Regulation of inflammatory response and cytokine signaling

Synergy with other bioregulatory peptides and immunostimulants

Due to its broad spectrum of action, Tα1 is a valuable model for studying the relationship between the immune system, stress, and recovery processes.

Possible Side Effects

In scientific literature, Thymosin Alpha-1 is generally well-tolerated. Reported reactions are rare and mild:

Mild redness or pain at the injection site

Transient fatigue or general malaise

Headache or dizziness at higher doses

No serious adverse reactions have been reported in research applications. Effects are dose-dependent and transient.

The information is based on scientific publications and is for educational purposes only. It is not intended for the diagnosis, treatment, or prevention of diseases.